Garland Capital Management’s St Jude Medical STJ Stock Holding History

Garland Capital Management’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-83,850	Closed	-$5.11M	–	31
2016 Q1	$5.11M	Sell	83,850 -1,050	-1%	-$57.2K	3.91%	7
2015 Q4	$5.24M	Sell	84,900 -650	-0.8%	-$41K	4.15%	3
2015 Q3	$5.4M	Buy	85,550 +8,750	+11%	+$625K	4.21%	1
2015 Q2	$5.61M	Sell	76,800 -11,050	-13%	-$798K	4.86%	1
2015 Q1	$5.75M	Sell	87,850 -100	-0.1%	-$6.65K	3.78%	2
2014 Q4	$5.72M	Buy	87,950 +1,900	+2%	+$122K	3.72%	3
2014 Q3	$5.17M	Sell	86,050 -1,200	-1%	-$78.4K	3.71%	2
2014 Q2	$6.04M	Hold	87,250	–	–	4.06%	1
2014 Q1	$5.71M	Buy	87,250 +150	+0.2%	+$9.76K	3.73%	1
2013 Q4	$5.4M	Sell	87,100 -450	-0.5%	-$26.1K	3.6%	2
2013 Q3	$4.7M	Sell	87,550 -550	-0.6%	-$28.3K	3.97%	3
2013 Q2	$4.02M	Buy	+88,100	New	+$3.82M	2.9%	9

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Garland Capital Management's STJ Position: Q2 2016 in Review

Garland Capital Management sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 83,850 shares — an estimated $5.11M sold.

Garland Capital Management first reported a position in STJ in Q2 2013 and held it in 12 quarters. The position peaked at $6.04M in Q2 2014. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

Garland Capital Management reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
Garland Capital Management sold 83,850 St Jude Medical shares in Q2 2016, an estimated $5.11M.
Garland Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 12 quarters.
Garland Capital Management's St Jude Medical position peaked at $6.04M in Q2 2014.
615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Garland Capital Management's 13F filing for Q2 2016, filed 18 Jul 2016.